Skip to main content
. 2012 Apr 18;2012(4):CD003964. doi: 10.1002/14651858.CD003964.pub3
Methods
  • Study design: RCT

  • Losses to follow‐up/withdrawals: None

Participants
  • Setting: inpatients recruited from paediatric department of general hospital

  • Country: China

  • Ethnicity: Chinese

  • Primary nephrotic syndrome diagnosed on "the National Diagnostic Criteria for Nephrotic Syndrome in Children", including simple nephrotic syndrome and nephritis nephrotic syndrome.

  • Course of disease: NS

  • Number: 46 children

  • Age range: 2 to 12 years

  • Gender (M/F): 30/16


Exclusion criteria: NS
Interventions Treatment group
  • Polyvalent vaccine (sublingually)

    • Dose: 7 drops bid

  • Baseline treatment including the standard steroid protocol for nephrotic children.

  • Duration of treatment: 4 weeks


Control group
  • Baseline treatment including the standard steroid protocol for nephrotic children.


Duration of follow‐up: NS
Outcomes
  • Nosocomial infection

    • Diagnostic criteria established by China

Notes
  • Spectrum of infection (number of patients)

    • Treatment group: URI (1); skin infection (1)

    • Control group: URI (4), pneumonia (2); UTI (2); skin infection (1)

  • Spectrum of microorganisms: NS

  • Source of funding: NS

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk The study did not provide the information on the method of random sequence generation, and only presented with the data as "all participants with nephrotic syndrome were randomly allocated to treatment and control groups".
Allocation concealment (selection bias) Unclear risk The study did not provide the information on allocation concealment.
Blinding (performance bias and detection bias) All outcomes Unclear risk The study did not provide the information on blinding.
Incomplete outcome data (attrition bias) All outcomes Low risk There were no missing data in this study.
Selective reporting (reporting bias) High risk Free of selective reporting bias was assessed as "No" due to some clinically important outcomes unstated, such as adverse effects of polyvalent vaccine.
Other bias Unclear risk There was insufficient information to make judgement.